The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy

Clinical Nephrology

Volumn 46, Issue 4, 1996, Pages 246-255

  Haller, H ^a   Drab, M ^b   Luft, F C ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Adhesion molecules; Advanced glycosylation end products; Atherosclerosis; Diabetes; Endothelial cells; Hyperglycemia; Matrix proteins; Protein kinase C

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOKINE; DIACYLGLYCEROL; GLUCOSE; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INOSITOL; INSULIN; INTERLEUKIN DERIVATIVE; MATRIX PROTEIN; MEMBRANE PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; PYRIDINE NUCLEOTIDE; RECEPTOR; SORBITOL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

BLOOD PRESSURE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE COURSE; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MORBIDITY; MORTALITY; PATHOGENESIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SYNTHESIS;

ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; GROWTH SUBSTANCES; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM;

EID: 0029839290     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (89)

1. Alkon DL, Rasmussen H 1988 A spatial-temporal model of cell activation. Science 239: 998-1005
2. Berk BC, Alexander RW, Brock TA, Gimbrone MA, Webb RC 1986 Vasoconstriction - a new role for platelet-derived growth factor. Science 232: 87-90
3. Brownlee M, Cerami A, Vlassara H 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321
4. Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A 1986 Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629-1632
5. Bucala R, Tracey KJ, Cerami A 1991 Advanced glycosylation products quench nitric oxide and mediate defective endothelium-depen- dent vasodilation in experimental diabetes. J Clin Invest 87: 432-438
6. Butkus A, Srinska VA, Schumacher OP 1980 Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. Thromb Res 19: 211-223
7. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M 1988 Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 82: 735-738
8. Cagliero E, Roth T, Roy S, Lorenzi M 1991 Characteristics and mechanisms of high-glucose-induced over - expression of basement membrane components in cultured human endothelial cells. Diabetes 40: 102-110
9. Capron L, Jarnet J, Kazandjian S, Housset E 1986 Growth-promoting effects of diabetes and insulin on arteries: an in vivo study of rat aorta. Diabetes 35: 973-978
10. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kamel WB 1986 Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 256: 2835-2838
11. Charonis AS, Reger LA, Dege JE, Kouzii-Koliakos K, Furcht LT, Wohlhueter RM, Tsilibary EC 1990 Laminin alterations after in vitro nonenzymatic glucosylation. Diabetes 39: 807-814
12. Chobanian AV 1990 Corcoran lecture: Adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension 15 (part 2): 666-674
13. Cliff WJ, Heathcote CR, Moss NS, Reichenbach DD 1988 The coronary arteries in cases of cardiac and noncardiac sudden death. Am J Pathol 132: 319-329
14. Craven PA, Davidson CM, DeRubertis FR 1990 Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39: 667-674
15. Craven PA, DeRubertis FR 1989 Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 83: 1667-1675
16. Crowley ST, Brownlee M, Edelstein D, Satriano J, Mori T, Singhal P, Schondorff D 1991 Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540-547
17. Diabetes in America: Diabetes Data Compiled 1984, 1985, NIH publication no. 85-1468
18. 2 formation and platelet sensitivity to prostacyclin in insulin-dependent and independent diabetics. Thromb Res 26: 359-370
19. Ducimetière P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G 1980 Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease in a middle aged population. Diabetologia 19: 205-210
20. Dzau VJ, Gibbons GH 1988 Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol 62: 30G-35G
21. Egleme C, Creesier F, Wood JM 1990 Local formation of angiotensin II in the rat aorta. Effect of endothelium. Brit J Pharmacol 100: 237-240
22. Epstein M, Sowers JR 1992 Diabetes mellitus and hypertension. Hypertension 19: 403-418
23. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H 1989 Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387-1407
24. Garcia MJ, McNamara PM, Gordon T, Kannel WB 1974 Morbidity and mortality in diabetics in the Framingham population: Sixteen-year follow-up study. Diabetes 23: 105-111
25. Gilcrease MZ, Hoover RL 1991 Examination of monocyte adherence to endothelium under hyperglycemic conditions. Am J Pathol 139: 1089-1097
26. Giles TD, Sander GE 1989 Myocardial disease in hypertensive-diabetic patients. Am J Med 87: 23S-28S
27. Gordon D, Relay MA, Benditt EP, Schwartz SM 1990 Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87: 4600-4604
28. Guerra R, Brotherton AFA, Goodwin PJ, Clark CR, Armstrong ML, Harrison DG 1989 Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: Implications for altered autocrine and paracrine functions of EDRF. Blood Vessels 26: 300-314
29. Haller H, Lindschau C, Quass P, Distler A 1991 High glucose concentration increase protein kinase C activity in vascular smooth muscle cells. J Hypertens 10: 145A
30. Haller H, Schaper D, Philipp S, Distler A 1992 LDL induces surface expression of adhesion molecules ICAM-1 and VCAM on endothelial cells via the activation of protein kinase C. J Am Soc Nephrol 3: 456
31. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M 1991 Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88: 11555-11558
32. Health Care Financing Administration Research Report. End Stage Renal Disease 1985 (1987): Baltimore. Office of Research and Demonstrations, Publication 03274
33. Hughes LO, Cruickshank JK, Wright J, Raftery EB 1989 Disturbances of insulin and its action in British Asian and white men surviving myocardial infarction. Br Med J 299: 537-541
34. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T 1989 Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1: 461-463
35. King GL, Goodman AD, Buzney S, Moses A, Kahn CR 1985 Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75: 1028-1036
36. Klein DJ, Oegema TR, Brown DM 1989 Release of glomerular heparan sulfate proteoglycan by heparin from glomeruli of streptozotocin induced diabetic rats. Diabetes 38: 130-139
37. Lamping KG, Dole WP 1987 Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ Res 61: 901-913
38. Lee TS, MacGregor LC, Fluharty SJ, King GL 1989 Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest 83: 90-94
39. Lee TS, Saltsman KA, Ohashi H, King GL 1989 Activation of protein kinase C by elevated glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86: 5141-5145
40. Logan RL, Riemersma RA, Thomson M, Oliver MF, Olsson AG, Walldius C, Rossner S, Kaijser L, Callmer E, Carlson LA, Lockerbie L Lutz W 1978 Risk factors for ischemic heart-disease in normal men aged 40: Edinburgh-Stockholm study. Lancet 1: 949-954
41. Lorenzi M, Cagliero E 1991 Pathobiology of endothelial and other vascular cells in diabetes mellitus; Call for data. Diabetes 40: 653-659
42. Lubec G, Pollak A 1980 Reduced susceptibility of nonenzymatically glycosylated glomerular basement membrane to proteases. Renal Physiol 3: 4-8
43. Lüscher TF 1990 Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension? Am J Hypertens 3: 317-330
44. Meraji S, Jayakody L, Senaratne MP, Thomson AB, Kappagoda T 1987 Endothelium-dependent relaxation in aorta of BB rat. Diabetes 36: 978-981
45. Morrison AD, Clements RS Jr. Travis SB, Oski F, Winegrad AI 1970 Glucose utilization by the polyol pathway in human erythrocytes. Biochem Biophys Res Commun 40: 199-205
46. Nathan C, Sporn M 1991 Cytokines in context. Cell 113: 981-986
47. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Liebow IM, Howard BV, Bennett PH 1990 Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81: 987-995
48. Nishizuka Y 1988 The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665
49. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE 1990 Endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27
50. Pfeifle B, Ditschuneit W 1981 Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 20: 155-158
51. Pober JS, Cotran RS 1990 Cytokines and endothelial cell biology. Physiol Rev 70: 427-451
52. Pyörälä K 1979 Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 2: 131-141
53. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J 1985 Plasma insulin as coronary heart disease risk factor. Relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 701: 38-52
54. Rasmussen H, Haller H, Kelley G, Park S, Takuwa Y 1990 Messenger Ca++, protein kinase C and smooth muscle contraction. In: Alan R (ed). Frontiers in Smooth Muscle Research. Liss., Inc. New York, pp 89-106
55. Reaven GM 1987 Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 3 (Suppl 1): 1-8-17
56. Rohrbach DH, Hasse JR, Kl.einmann HK, Martin GR 1982 Alterations in basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes 31: 185-188
57. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL 1991 Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest 87: 139-147
58. Ross R 1986 The pathogenesis of atherosclerosis: An update. N Engl J Med 314: 488-500
59. Roy S, Sala R, Cagliero E, Lorenzi M 1990 Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 87: 404-408
60. Scharf RE, Harker LA 1987 Thrombosis and atherosclerosis: Regulatory role of interactions among blood components and endothelium. Blut 55: 131
61. Schwartz SM, Heimarck RL, Majesty MW 1990 Developmental mechanisms underlying pathology of arteries. Physiol Rev 70: 1177-1209
62. Simionescu M, Simionescu N 1986 Functions of the endothelial cell surface. Annu Rev Physiol 48: 279-304
63. Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, Sedor JR, Dunn MJ 1989 Endothelin stimulates phospholipase C, Na/H exchange, c-fos expression, mitogenesis in rat mesangial cells. J Clin Invest 83: 708-712
64. C with prevalent cardiovascular disease in the original cohort of the Framingham Study. Diabetes 41: 202-209
65. Skyler JS 1990 Relation of metabolic control of diabetes mellitus to chronic complications. In: Rifken H, Porte D Jr (eds). Diabetes Mellitus, Theory and Practice. Elsevier, New York, pp 856-868
66. Soules-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G 1991 Retardation by aminoguanidine of development of albuminuria mesangial expansion and tissue fluorescence in streptozotocin induced diabetic rat. Diabetes 40: 1328-1335
67. Springer TA 1990 The sensation and regulation of interactions with the extracellular environment: The cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 6: 359-402
68. Steinberg D, Witztum JL 1990 Lipoproteins and atherogenesis: Current concepts. JAMA 264: 3047-3052
69. Steiner G 1981 Diabetes and atherosclerosis: An overview. Diabetes 30 (Suppl 2): 1-7
70. Stout RW 1990 Insulin and atheroma. 20-yr perspective. Diabetes Care 13: 631-654
71. 2 formation and platelet sensitivity to prostacyclin in insulin-dependent and independent diabetics. Thromb Res 26: 359-370
72. Stout RW, Bierman EL, Ross R 1975 Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 36: 319-327
73. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR 1990 Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306-310
74. Tesfamariam B, Brown ML, Deykin D, Cohn RA 1990 Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85: 929-932
75. Tesfamariam B, Brown ML, Cohen RA 1991 Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87: 1643-1648
76. Tsilbary EC, Charonis AS, Reger LA, Wohlhueter RM, Furcht LT 1988 The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem 263: 4302-4308
77. Tsilibary EC, Charonis AS 1990 The effect of non-enzymatic glucosylation on cell and heparin-binding microdomains from type IV collagen and laminin. Diabetes 39: 194A
78. Vlassara H, Brownlee M, Monogue K, Dinarello CA, Pasagian A 1988 Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546-1548
79. Vracko R 1982 A comparison of the microvascular lesions in diabetes mellitus with those of normal aging. J Am Geriatr Soc 30: 201-205
80. Weinstein R, Stemerman MB, Maciag T 1981 Hormonal requirements for growth of arterial smooth muscle cells in vitro: an endocrine approach to atherosclerosis. Science 212: 818-820
81. Welborn TA, Wearne K 1979 Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154-160
82. West KM 1978 Epidemiology of Diabetes and Its Vascular Lesions. Elsevier Science Publishing Co. Inc., New York, pp 579-612
83. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, Barlow GK, Stephenson SH, Lalouel JM, Kuida H 1988 Familial dyslipidemic hypertension: Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 259: 3579-3586
84. Williams E, Timperley WR, Ward JD, Duckworth T 1980 Electron microscopic studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33: 462-470
85. Williamson JR, Wolf BA, Ostrow E, Turk J 1990 Relationship of glucose-induced vascular function changes to diacylglycerol (DAG) levels and protein kinase C (PKC) activity. Diabetes 93: 157A
86. Winegrad AI 1987 Does a common mechanism induce the diverse complications of diabetes? Diabetes 6: 396-406
87. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J 1991 Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87: 31-38
88. Yamouchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H 1990 Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 267: 16-18
89. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven GM 1989 Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702-706